Anthracene

Anthracene

SCHEMBL7109280

CC(=O)n1ccnc1.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.44
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
CYP24A1 Q07973 1/20 0.41
FAAH O00519 2/20 0.40
MGLL Q99685 2/20 0.40
NOTUM Q6P988 1/20 0.40
CYP26A1 O43174 3/20 0.39
CYP3A4 P08684 1/20 0.39
BAZ2B Q9UIF8 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25507680 0.83
SCHEMBL26238 0.83
Quinoline SCHEMBL27817062 0.83 ALDH1A1 (0.50) CYP19A1CYP11B1CYP11B2CYP24A1FAAH
SCHEMBL28509375 0.81
SCHEMBL28429143 0.76 CYP3A4 (0.37) CYP19A1CYP24A1FAAHMGLLCYP3A4
SCHEMBL1186098 0.76 CES2 (0.49) CYP19A1CYP11B1CYP11B2LMNA
Phenylpyruvate SCHEMBL28776087 0.75 CES2 (0.44) CYP19A1CYP11B1CYP11B2CYP24A1FAAH
Naphthalene SCHEMBL7446184 0.75 FAAH (0.42) CYP19A1CYP11B1CYP11B2CYP24A1FAAH
SCHEMBL31564903 0.73 BCHE (0.48) CYP19A1CYP11B1CYP11B2ALDH1A1LMNA
Anthracene SCHEMBL27725162 0.72 NFKB1 (0.62) CYP19A1CYP11B1CYP11B2CYP26A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030092067-A1 Substrates and inhibitors of proteolytic enzymes PEPTIDE THERAPEUTICS LIMITED 2003-05-15 US disclosed
US-6528275-B1 Screening for cleavage using combinatorial fluorescence resonance energy transfer (FRET) compounds of given formula; can use to accelerate drug discovery process PEPTIDE THERAPEUTICS LIMITED (GB) 2003-03-04 US disclosed
EP-0906333-B1 SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES MEDIVIR UK LTD (GB) 2001-07-25 EP disclosed
EP-0906333-A2 SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES PEPTIDE THERAPEUTICS LIMITED (GB) 1999-04-07 EP disclosed
EP-0906334-A1 AUTO-DECONVOLUTING COMBINATORIAL LIBRARIES PEPTIDE THERAPEUTICS LIMITED (GB) 1999-04-07 EP disclosed
WO-1997042216-A1 AUTO-DECONVOLUTING COMBINATORIAL LIBRARIES PEPTIDE THERAPEUTICS LIMITED (GB) 1997-11-13 WO disclosed
WO-1997040065-A2 SUBSTRATES AND INHIBITORS OF PROTEOLYTIC ENZYMES PEPTIDE THERAPEUTICS LIMITED (GB) 1997-10-30 WO disclosed